October 7, 2024 10:30 AM EDTUpdated 12:54 PM
Special

Spe­cial re­port 2024: Meet 20 women break­ing new ground in bio­phar­ma R&D

ENDPOINTS

Ded­i­cat­ed to the mem­o­ry of Na­tal­ie Grover, who co-cre­at­ed the Women in Bio­phar­ma R&D spe­cial re­port while she was a re­porter at End­points from …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

Pfiz­er tar­get­ed by ac­tivist, fol­low­ing post-pan­dem­ic stum­bles — re­ports

Ju­do Bio launch­es with $100M for kid­ney-tar­get­ed siR­NA ther­a­pies

Up­stream and CAMP4 tar­get $182M, $67M IPOs

FDA puts Kezar lu­pus tri­al on hold af­ter ear­li­er re­port of pa­tient deaths

Schol­ar Rock claims suc­cess in Phase 3 spinal mus­cu­lar at­ro­phy study, stock soars

As­traZeneca makes an­oth­er car­dio deal, bet­ting $100M on Chi­na com­pa­ny’s lipid drug

A service from the Financial Times